Peak6 Investments LLC Novavax Inc Call Options Transaction History

Peak6 Investments LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	SELL	$3.89 - $20.97 $716,149 - $3.86 Million	-184,100 Reduced 89.59%	21,400 $270,000
Q1 2024 May 14, 2024	BUY	$3.76 - $6.02 $772,680 - $1.24 Million	205,500 New	205,500 $982,000
Q4 2022 Feb 10, 2023	BUY	$8.86 - $25.04 $253,395 - $716,144	28,600 New	28,600 $294,000
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $1.88 Million - $3.9 Million	-51,800 Reduced 51.75%	48,300 $2.48 Million
Q1 2022 May 13, 2022	SELL	$69.73 - $142.9 $397,461 - $814,530	-5,700 Reduced 5.39%	100,100 $7.37 Million
Q4 2021 Feb 11, 2022	BUY	$134.56 - $217.97 $1.39 Million - $2.25 Million	10,300 Added 10.79%	105,800 $15.1 Million
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $7.5 Million - $11.4 Million	42,200 Added 79.17%	95,500 $19.8 Million
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $6.45 Million - $13.7 Million	53,300 New	53,300 $11.3 Million

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $674M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.